118
Views
77
CrossRef citations to date
0
Altmetric
Special Contributions

Benzene-induced Cancers: Abridged History and Occupational Health Impact

Pages 213-221 | Published online: 19 Jul 2013

References

  • Infante PF. The past suppression of industry knowledge of the toxicity of benzene to humans and potential bias in future ben-zene research. Int J Occup Environ Health. 2006; 12: 268–72.
  • Huff J, Haseman JK, DeMarini DM, et al Multiple site carcino-genicity of benzene in Fischer 344 rats and B6C3F1 mice. Env-iron Health Perspect. 1989; 82: 125–63.
  • Huff J. Value, validity, and historical development of carcino-genesis studies for predicting and confirming carc in ogenic risks to humans. Chapter 2: 21-123. In: Kitchin KT (ed). Car-cinogenicity Testing, Predicting, 8c Interpreting Chemical Effects. New York: Marcel Dekker, 1999.
  • Tomatis L. The predictive value of rodent carcinogenicity tests in the evaluation of human risks. Annu Rev Pharmacol Toxicol. 1979; 19: 511–30.
  • Huff J. Chemicals and cancer in humans: first evidence in ex-perimental animals. Environ Health Perspect. 1993; 100: 201–10.
  • 'ARC. Preamble 9-31. In: Formaldehyde, 2-butoxyethanol and 1-tert-butoxypropan-2-ol. IARC Managr Eval Carcinog Risks Hum. 2006 Dec; 88: 1–478.
  • Grandjean P, Gailar JC, Gee D., et al Implications of the pre-cautionary principle in research and policy-making. Am J Ind Med. 2004; 45: 382–5.
  • Tickner JA. Precautionary principle encourages policies that protect human health and the environment in the face of uncertain risks. Public Health Rep. 2002; 117: 493–7.
  • Stirling A. Risk, precaution and science: towards a more con-structive policy debate. Talking point on the precautionary principle. EMBO Rep. 2007; 8: 309–15.
  • Ozonoff D. On being careful what we wish for: some difficulties with operationalizing the precautionary principle. Int J Occup Med. Environ Health. 2004; 17: 3541.
  • IARC. Benzene. IARC Monogr Eval Carcinog Risk Chem Hum. 1974; 7: 203–21.
  • IARC. Benzene. IARC Monogr Eval Carcinog Risk Chem Hum. 1982; 29: 93–148, 391–8.
  • IARC. Benzene. IARC Monogr Eval Carcinog Risk Chem Hum. 1987;suppl 7: 120-2.
  • Infante PF, Rinsky RA, Wagoner JK, Young RJ. Leukaemia in benzene workers. Lancet. 1977;9;2 (8028) 76-8.
  • Infante PF, White MC. Projections of leukemia risk associated with occupational exposure to benzene. Am J Ind Med. 1985;7(5–6) :403–13.
  • NTP RoC. Benzene. In: 11th Report on Carcinogens, 2004. National Toxicology Program, Research Triangle Park, NC 27709. http://ntp-server.niehs.nih.gov/ntp/roc/eleventh/profiles/s019benz.pdf.
  • ATSDR. Toxicological Profile for Benzene. Draft for Public Comment September 2005. Agency for Toxic Substances and Disease Registry, 1825 Century Blvd, Atlanta, GA 30345 http://www.atsdr.cdc.gov/toxprofiles/tp3.html.
  • Infante PF. Benzene exposure and multiple myeloma: a detailed meta-analysis of benzene cohort studies. Ann NYAcad Sci. 2006; 1076: 90409.
  • Yin SN, Hayes RB, Linet MS., et al A cohort study of cancer among benzene-exposed workers in China: overall results. Am J Ind Med. 1996; 29: 227–35.
  • Yin SN, Hayes RB, Linet MS., et al An expanded cohort study of cancer among benzene-exposed workers in China. Benzene Study Group. Environ Health Perspect. 1996;104 suppl 6: 1339–41.
  • Hayes RB, Yin SN, Dosemeci M., et al Mortality among ben-zene-exposed workers in China. Environ Health Perspect. 1996;104 suppl 6: 1349–52.
  • Hayes RB, Yin SN, Dosemeci M., et al Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine-National Cancer Institute Benzene Study Group. J Natl Cancer Inst. 1997; 89: 1065–71.
  • Smith MT, Jones RM, Smith AH. Benzene exposure and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prey. 2007; 16: 385–91.
  • Hayes RB, Songnian Y, Dosemeci M, Linet M. Benzene and lymphohematopoietic malignancies in humans. Am J Ind. Med. 2001; 40: 117–26.
  • Parmeggiani A, Prodi G, Maltoni C. [Incorporation of radioac-tive sulfate in sulfurated polysaccharides of rabbit skin during treatment with cocarcinogenic substance (Croton oil)]. Boll Soc Ital Biol Sper. 1957; 33: 496–9. [In Italian]
  • Maltoni C, Prod i G. [Cutaneous oncogenesis in Cricetus auratus (hamster) by 9,10-dimethy1-1,2-benzanthracene.] Boll Soc Ital Biol Sper. 1957; 33: 506–7. [In Italian]
  • Maltoni C, Lefemine G. Carcinogenicity bioassays of vinyl chlo-ride. I. Research plan and early results. Environ Res. 1974;:387–405.
  • Warren H, HuffJ. Health effects of vinyl chloride monomer: an annotated literature collection. Environ Health Perspect. 1975; 11: 251–319.
  • Infante PF. Oncogenic and mutagenic risks in communities with polyvinyl chloride production facilities. Ann NYAcad Sci. 1976; 271: 49–57.
  • Maltoni C. Biomedical research as a science for development: the case of gasoline. Ramazzini Lecture, 1995. Ann NY Acad Sci. 1997; 837: 1–14.
  • Maltoni C, Ciliberti A, Pinto C, Soffritti M, Belpoggi F, Menar-ini L. Results of long-term experimental carcinogenicity studies of the effects of gasoline, correlated fuels, and major gasoline aromatics on rats. Ann NYAcad Sci. 1997; 837: 15–52.
  • Belpoggi F, Soffritti M, Maltoni C. Methyl-tertiary-butyl ether (MTBE)-a gasoline additive-causes testicular and lympho-haematopoietic cancers in rats. Toxicol Ind Health. 1995; 11: 119–49.
  • Belpoggi F, Soffritti M, Filippini F, Maltoni C. Results of long-term experimental studies on the carcinogenicity of methyl tert-butyl ether. Ann NYAcad Sci. 1997; 837: 77–95.
  • Soffritti M, Maltoni C, Maffei F, Biagi R. Formaldehyde: an experimental multipotential carcinogen. Toxicol Ind Health. 1989;5699–730.
  • Soffritti M, Belpoggi F, Cevolani D, Guarino M, Padovani M, Maltoni C. Results of long-term experimental studies on the carcinogenicity of methyl alcohol and ethyl alcohol in rats. Ann NYAcad Sci. 2002; 982: 46–69.
  • Maltoni C. The contribution of experimental (animal) studies to the control of industrial carcinogenesis. Appl Occup Envi-ron Hyg. 1995; 10: 749–60.
  • Maltoni C, Soffritti M, Belpoggi F. The scientific and method-ological bases of experimental studies for detecting and quan-tifying carcinogenic risks. Ann NYAcad Sci. 1999; 895: 10–26.
  • Soffritti M, Belpoggi F, Minardi F, Maltoni C. Ramazzini Foun-dation cancer program: history and major projects, life-span carcinogenicity bioassay design, chemicals studied, and results. Ann NYAcad Sci. 2002; 982: 26–45. '
  • Mehlman MA. Carcinogenic effects of benzene: Cesare Mal-toni's contributions. Ann NYAcad Sci. 2002;98213748.
  • Maltoni C, Scarnato C. First experimental demonstration of the carcinogenic effects of benzene; long-term bioassays on Sprague-Dawley rats by oral administration. Med Lay. 1979; 70: 352–7.
  • Maltoni C, Cotti G, Valgimigli L, Mandrioli A. Zymbal gland carcinomas in rats following exposure to benzene by inhala-tion. Am J Ind Med. 1982; 3: 11–6.
  • Maltoni C, Conti B, Scarnato C. Squamous cell carcinomas of the oral cavity in Sprague-Dawley rats, following exposure to benzene by ingestion. First experimental demonstration. Med Lan 1982; 73: 441–5.
  • Maltoni C, Cotti G, Valgimigli L, Mandrioli A. Hepatocarcino-mas in Sprague-Dawley rats, following exposure to benzene by inhalation. First experimental demonstration. Med Lan 1982; 73: 446–50.
  • Maltoni C, Conti B, Cotti G. Benzene: a multipotential car-cinogen. Results of long-term bioassays performed at the Bologna Institute of Oncology. Am J hid Med. 1983;:589–630
  • Maltoni C, Conti B, Cotti G, Belpoggi F. Experimental studies on benzene carcinogenicity at the Bologna Institute of Oncol-ogy: current results and ongoing research. Am J Ind Med. 1985; 7 (5–6): 415–46.
  • Maltoni C, Conti B, Perino G, Di Maio V. Further evidence of benzene carcinogenicity. Results on Wistar rats and Swiss mice treated by ingestion. Ann NYAcad Sci. 1988; 534: 412–26.
  • Maltoni C, Ciliberti A, Cotti G, Conti B, Belpoggi F. Benzene, an experimental multipotential carcinogen: results of the long-term bioassays performed at the Bologna Institute of Oncol-ogy. Environ Health Perspect. 1989; 82: 109–24.
  • Huff J. Carcinogenesis bioassay results from the National Toxi-cology Program. Environ Health Perspect. 1982; 45: 185–98.
  • Huff J, Moore JA. Carcinogenesis studies design and experi-mental data interpretation/evaluation at the National Toxicol-ogy Program. Prog Clin Biol Res. 1984; 141: 43–64.
  • Chhabra RS, Huff JE, Schwetz BS, Selkirk J. An overview of prechronic and chronic toxicity/carcinogenicity experimental study designs and criteria used by the National Toxicology Pro-gram. Environ Health Perspect. 1990; 86: 313–21.
  • Huff J, Haseman J. Long-term chemical carcinogenesis experi-ments for identifying potential human cancer hazards: collec-tive database of the National Cancer Institute and National Toxicology Program (1976-1991). Environ Health Perspect. 1991; 96: 23–31.
  • Huff J. Design strategies, results and evaluations of long-term chemical carcinogenesis studies. Scand J Work Environ Health. 1992;18 suppl 1: 31-7.
  • Huff J. A historical perspective on the classification developed and used for chemical carcinogens by the National Toxicology Program during 1983-1992. Scand J Work Environ Health. 1992;18 suppl 1: 74-82.
  • Haseman J, Melnick R, Toniatis L, HuffJ. Carcinogenesis bioas-says: study duration and biological relevance. Food Chem Tox-icol. 2001; 39: 739–44.
  • Bucher JR. The National Toxicology Program rodent bioassay: designs, interpretations, and scientific contributions. Ann NY Acad Sci. 2002; 982: 198–207.
  • Huff J. The legacy of David Platt Rail. Scientific, environmen-tal, public health, and regulatory contributions. Eur J Oncol. 2000; 5: 85–100.
  • Huff J. David Rail and the national toxicology program. Envi-ron Health Perspect. 2005; 113: A152.
  • Hammons AS, Lewis EB, Braunstein HM, Huff J. Arsenic: Potential hazards of environmental exposures. In: Environ-mental Chemicals: Human and Animal Health Proceedings IV. 1976;75–93.
  • Chan P, Huff J. Arsenic carcinogenesis in animals and in humans: mechanistic, experimental, and epidemiological evi-dence. Environ Carcinog Ecotox Revs. 1997;C15: 83-122.
  • Huff J, Waalkes M, Chan P. Arsenic-evidence of carcinogenic-ity in animals. Environ Health Perspect. 1998;106A582-A583.
  • Huff J, Chan P, Nyska A. Is the human carcinogen arsenic car-cinogenic to laboratory animals? Toxicol Sci. 2000; 55: 17–23.
  • Waalkes MP, Ward JM, Liu J, Diwan BA. Transplacental car-cinogenicity of inorganic arsenic in the drinking water: induc-tion of hepatic, ovarian, pulmonary, and adrenal tumors in mice. Toxicol Appl Pharmacol. 2003; 186: 7–17.
  • Waalkes MP, Ward JM, Diwan BA. Induction of tumors of the liver, lung, ovary and adrenal in adult mice after brief maternal gestational exposure to inorganic arsenic: promotional effects of postnatal phorbol ester exposure on hepatic and pul-monary, but not dermal cancers. Carcinogenesis. 2004; 25: 133–41.
  • Waalkes MP, Liu J, Ward JM, Diwan BA. Mechanisms underly-ing arsenic carcinogenesis: hypersensitivity of mice exposed to inorganic arsenic during gestation. Toxicology. 2004; 198: 31–8.
  • Huff J, National Toxicology Program. NTP Toxicology and Car-cinogenesis Studies of Benzene (CAS No. 71-43-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Natl Toxicol Program Tech Rep Ser. 1986; 289: 1–277.
  • Huff J, Eastin W, Roycroft J, Eustis SL, Haseman JK. Carcino-genesis studies of benzene, methyl benzene, and dimethyl ben-zenes. Ann NYAcad Sci. 1988; 534: 427–40.
  • Huff J. Chemicals studied and evaluated in long-term carcino-genesis bioassays by both the Ramazzini Foundation and the National Toxicology Program: in tribute to Cesare Maltoni and David Rail. Ann NYAcad Sci. 2002; 982: 208–30.
  • Breilh J, Branco Jefer C, Castelman BI., et al Texaco and its consultants. Int J Occup Environ Health. 2005; 11: 217–20.
  • Huff J. Industry influence on occupational and environmental public health. Int J Occup Environ Health. 2007; 13: 107–17.
  • Bailar JC 3rd. How to distort the scientific record without actu-ally lying: truth, and the arts of science. Fur J Oncol. 2006; 11: 217–24.
  • Tomatis L, Aitio A, Wilbourn J, Shuker L. Human carcinogens so far identified. Jpn J Cancer Res. 1989; 80: 795–807.
  • Huff J. Chemicals causally associated with cancers in humans and in laboratory animals: a perfect concordance. Chapter 2: 25-37. In: Waalkes MP, Ward JM (eds). New York: Carcinogen-esis. Raven Press, 1994.
  • Huff J. Chemically associated respiratory carcinogenesis in rodents and in humans. Chapter 7: 199-214. In: Waalkes MP, Ward JM (eds). Carcinogenesis. New York: Raven Press, 1994.
  • Huff J. Animal and human carcinogens. Environ Health Per-spect. 1999; 107: A.341–2.
  • Tomatis L, Huff J, Hertz-Picciotto I., et al Avoided and avoid-able risks of cancer. Carcinogenesis. 1997; 18: 97–105.
  • Tomatis L. The identification of human carcinogens and pri-mary prevention of cancer. Mutat Res. 2000; 462: 407–21.
  • Tomatis L, Melnick RL, Haseman J, Barrett JC, Huff J. Alleged misconceptions' distort perceptions of environmental cancer risks. FASEB J. 2001; 15: 195–203.
  • Delore P, Borgomano C. Leucemie aique au cours de l'intoxi-cation benzenique. Sur l'origine toxique de certaines leucemies aigues et leurs relations avec les anemies graves. J Med Lyon. 1928; 9: 227–33. [In French]
  • Li G, Yin S. Progress of epidemiological and molecular epi-demiological studies on benzene in China Ann NYAcad Sci. 2006; 1076: 800–9.
  • Kuang S, Liang W. Clinical analysis of 43 cases of chronic ben-zene poisoning. Chem Biol Interact. 2005;153-154: 129-35.
  • Landrigan PJ. Benzene and blood: one hundred years of evi-dence. Am J Ind Med. 1996; 29: 225–6.
  • Shu XO, Gao YT, Brinton LA., et al A population-based case-control study of childhood leukemia in Shanghai. Cancer. 1988; 62: 635–44.
  • Adegoke 0J, Blair A, Shu XO, et al. Occupational history and exposure and the risk of adult leukemia in Shanghai. Ann Epi-demiol. 2003; 13: 485–94.
  • Glass DC, Gray CN, Jolley DJ., et al Leukemia risk associated with low-level benzene exposure. Epidemiology. 2003; 14: 569–77.
  • Glass DC, Gray CN, Jolley DJ, Gibbons C, Sim MR. The health watch case-control study of leukemia and benzene: the story so far. Ann NYAcad Sci. 2006 sep; 1076: 80-9.
  • Glass DC, Sim MR, Fritschi L, Gray CN, Jolley DJ, Gibbons C. Leukemia risk and relevant benzene exposure period-Re: follow-up time on risk estimates. Am J Ind Med. 2002; 41: 481-9; 2004; 45: 222–3.
  • Glass DC, Gray CN, Jolley DJ, Gibbons C, Sim MR Health watch exposure estimates: do they underestimate benzene exposure? Chem Biol Interact. 2005;153-154: 23-32.
  • Huff J, Melnick RL, Solleveld HA, Haseman JK, Powers M, Miller RA. Multiple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure. Science. 1985; 227 (4686): 548–9.
  • Melnick RL, Huff J, Chou BJ, Miller RA. Carcinogenicity of 1,3-butadiene in C57BL/6 X C3H Fl mice at low exposure con-centrations. Cancer Res. 1990; 50: 6592–9.
  • Melnick RL, Kamel F, Huff J. Declaring chemicals “not car-cinogenic to humans” requires validation, not speculation. Environ Health Perspect. 2003; 111: A2034.
  • Haseman JK. An alternative perspective: a critical evaluation of the Waddell threshold extrapolation model in chemical car-cinogenesis. Toxicol Pathol. 2003; 31: 468–70.
  • Huff J. Mechanisms, chemical carcinogenesis, and risk assess-ment: cell proliferation and cancer. Am J Ind Med. 1995; 27: 293–300.
  • Melnick RL, Kohn MC, Portier CJ. Implications for risk assess-ment of suggested nongenotoxic mechanisms of chemical carcinogenesis. Environ Health Perspect. 1996;104 suppl 1: 123-34.
  • Barrett JC, Huff J. Cellular and molecular mechanisms of chemically induced renal carcinogenesis. Ren Fail. 1991; 13: 211–25.
  • Melnick RL. An alternative hypothesis on the role of chemi-cally induced protein droplet (alpha 2u-globulin) nephropathy in renal carcinogenesis. Regul Toxicol Pharmacol. 1992; 16: 111–25.
  • Melnick RL. Critique does not validate assumptions in the model on alpha 2u-globulin and renal carcinogenesis. Regul Toxicol Pharmacol. 1993; 18: 365–8.
  • Huff J. Alpha-2u-globulin nephropathy, posed mechanisms, and white ravens. Environ Health Perspect. 1996; 104: 1264–7.
  • Melnick RL, Kohn MC, Huff J. Weight of evidence versus weight of speculation to evaluate the alpha2u-globulin hypoth-esis. Environ Health Perspect. 1997; 105: 904–6.
  • Melnick RL. Is peroxisome proliferation an obligatory precur-sor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)? Environ Health Perspect. 2001; 109: 437–42.
  • Melnick RL. The IARC evaluation of di (2-ethylheicyl)phthalate (DEHP): a flawed decision based on an untested hypothesis. Int J Occup Environ Health. 2002; 8: 284–6.
  • Thayer KA, Melnick R, Burns K, Davis D, Huff J. Fundamental flaws of hormesis for public health decisions. Environ Health Perspect. 2005; 113: 1271–6.
  • Thayer KA, Melnick R, Huff J, Burns K, Davis D. Hormesis: a new religion? Environ Health Perspect. 2006; 114: A632–3.
  • Melnick RL. Does chemically induced hepatocyte proliferation predict liver carcinogenesis? FASEB J. 1992; 6: 2698-706.
  • Melnick RL, Huff J, Barrett JC, Maronpot RR, Lucier G, Portier CJ. Cell proliferation and chemical carcinogenesis: a sympo-sium overview. Mol Carcinog. 1993; 7: 135–8.
  • Melnick RL, HuffJ. Liver carcinogenesis is not a predicted outcome of chemically induced hepatocyte proliferation. Toxicol Ind Health. 1993; 9: 415–38.
  • Ward JM, Uno H, Kurata Y, Weghorst CM, Jang JJ. Cell prolif-eration not associated with carcinogenesis in rodents and humans. Environ Health Perspect. 1993;101 suppl 5: 125-35.
  • Tomatis L. Cell proliferation and carcinogenesis: a brief history and current view based on an IARC workshop report. Interna-tional Agency for Research on Cancer. Environ Health Per-spect. 1993;101 suppl 5: 149-51.
  • Farber E. Cell proliferation as a major risk factor for cancer: a concept of doubtful validity. Cancer Res. 1995; 55: 3759–62.
  • Farber E. Cell proliferation is not a major risk factor for cancer. Mod Pathol. 1996; 9: 606.
  • Hoel DG, Haseman JK, Hogan MD, Huff J, McConnell EE. The impact of toxicity on carcinogenicity studies: implications for risk assessment. Carcinogenesis. 1988; 9: 2045–52.
  • Huff J. Chemical toxicity and chemical carcinogenesis. Is there a causal connection? A comparative morphological evaluation of 1500 experiments. IARC Sci Publ. 1992;(116):437-75.
  • Huff J. Absence of morphologic correlation between chemical toxicity and chemical carcinogenesis. Environ Health Perspect. 1993;101 suppl 5: 45-53.
  • Huff J, Boyd J, Barrett JC (eds). Cellular and molecular mech-anisms of hormonal carcinogenesis: environmental influences. Prog Clin Biol Res. 1996; 394: i-xix; 1-479.
  • Huff J, Boyd J, Barrett JC. Hormonal carcinogenesis and envi-ronmental influences: background and overview. Prog Clin Biol Res. 1996; 394: 3–23.
  • Huff J. Chemically induced cancers in hormonal organs of lab-oratory animals and of humans. Prog Clin Biol Res. 1996; 394: 77–102.
  • Maronpot RR, Haseman JK, Boorman GA, Eustis SE, Rao GN, Huff J. Liver lesions in B6C3F1 mice: the National Toxicology Program, experience and position. Arch Toxicol. 1987;10 supp1: 10-26.
  • Huff J, Eustis SL, Haseman JK. Occurrence and relevance of chemically induced benign neoplasms in long-term carcino-genicity studies. Cancer Metastasis Rev. 1989; 8: 1–22. Erratum in: Cancer Metastasis Rev 1989; 8: 281.
  • Huff J. Applicability to humans of “rodent-specific sites” of chemical carcinogenicity: tumors of the forestomach and of the harderian, preputial, and zymbal glands induced by ben-zene. J Occup Med Toxicol. 1992; 1: 109–41.
  • White MC, Infante PF, Walker BJr. Occupational exposure to benzene: a review of carcinogenic and related health effects following the U.S. Supreme Court decision. Am J Ind Med. 1980; 1: 233–43.
  • Tsutsui i, Hayashi N, Maizumi H, HuffJ, Barrett JC. Benzene-, catechol-, hydroquinone- and phenol-induced cell transforma-tion, gene mutations, chromosome aberrations, aneuploidy, sister chromatid exchanges and unscheduled DNA synthesis in Syrian hamster embryo cells. Mutat Res. 1997; 373: 113–23.
  • Whysner J, Reddy MV, Ross PM, Mohan M, Lax EA. Genotoxi-city of benzene and its metabolites. Mutat Res. 2004;566):99–130.
  • Hirose M, Fukushima S, Shirai T., et al Stomach carcinogenic-ity of caffeic acid, sesamol and catechol in rats and mice. Jpn J Cancer Res. 1990; 81: 207–12.
  • Hirose M, Fukushima S, Tanaka H, Asakawa E, Takahashi S, Ito N. Carcinogenicity of catechol in F344 rats and B6C3F1 mice. Carcinogenesis. 1993; 14: 525–9.
  • IARC. Catechol. IARC Monogr Eval Carcinog Risks Hum. 1999; 71 Pt 2: 433–51.
  • Hirose M, Hakoi K, Takahashi S., et al Sequential morphologi-cal and biological changes in the glandular stomach induced by oral administration of catechol to male F344 rats. Toxicol Pathol. 1999; 27: 448–55.
  • Hagiwara A, Takesada Y, Tanaka H., et al Dose-dependent induction of glandular stomach preneoplastic and neoplastic lesions in male F344 rats treated with catechol chronically. Tox-icol Pathol. 2001; 29: 180–6.
  • Karl F, National Toxicology Program. NTP Toxicology and Car-cinogenesis Studies of Hydroquinone (GAS No. 123-31-9) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Natl Toxicol Program Tech Rep Ser. 1989 Oct; 366: 1–248.
  • Karl FW, Bucher J, Eustis SL, Haseman JK, Huff J. Toxicity and carcinogenicity of hydroquinone in F344/N rats and B6C3F1 mice. Food Chem Toxicol. 1992; 30: 737–47.
  • Shibata MA, Hirose M, Tanaka H, Asakawa E, Shirai T, Ito N. Induction of renal cell tumors in rats and mice, and enhance-ment of hepatocellular tumor development in mice after long-term hydroquinone treatment. Jpn J Cancer Res. 1991; 82: 1211–9.
  • IARC. Hydroquinone. IARC Monogr Eval Carcinog Risks Hum. 1999;71 Pt 2: 691–719.
  • Huff J, National Toxicology Program. Bioassay of Phenol for Possible Carcinogenicity (CAS No.108-95-2). Nad Toxicol Pro-gram Tech Rep Ser. 1980 Aug; 203: 1–123.
  • Huff J. Carcinogenesis results on seven amines, two phenols, and one diisocyanate used in plastics and synthetic elastomers. Prog Clin Biol Res. 1984; 141: 347–63.
  • IARC. Phenol. IARC Monogr Eval Carcinog Risks. Hum. 1999;71 Pt 2: 749–68.
  • Gopalakrishna R, Chen ZH, Gundimeda U. Tobacco smoke tumor promoters, catechol and hydroquinone, induce oxida-tive regulation of protein kinase C and influence invasion and metastasis of lung carcinoma cells. Proc Nati Acad Sci USA. 1994; 91: 12233–7.
  • Rothman N, Bechtold WE, Yin SN., et al Urinary excretion of phenol, catechol, hydroquinone, and muconic acid by workers occupationally exposed to benzene. Occup Environ Med. 1998; 55: 705–11.
  • Golding BT, Watson WP. Possible mechanisms of carcinogene-sis after exposure to benzene. IARC Sci Publ. 1999; 150: 75–88.
  • Lau SS, Monks TJ, Everitt JI, Kleymenova E, Walker CL. Car-cinogenicity of a nephrotoxic metabolite of the “nongeno-toxic” carcinogen hydroquinone. Chem Res Toxicol. 2001; 14: 25–33.
  • Rall DP. The role of laboratory animal studies in estimating car-cinogenic risks for man. IARC Sci Publ. 1979; 25: 179–89.
  • Huff J, Moore J, Rall D. The National Toxicology Program and preventive oncology. In: Estrin N (ed). The Cosmetic Industry: Scientific and Regulatory Foundations, N Estrin (ed). New York: Marcel Dekker, 1984; 647-76.
  • Rail DP. Relevance of animal experiments to humans. Environ Health Perspect. 1979; 32: 297–30.
  • Rall DP, Hogan MD, Huff JE, Schwetz BA, Tennant RW. Alter-natives to using human experience in assessing health risks. Annu Rev Public Health. 1987; 8: 355–85.
  • Haseman JK, Huff JE, Zeiger E, McConnell EE. Comparative results of 327 chemical carcinogenicity studies. Environ Health Perspect. 1987; 74: 229–35.
  • Huff J, McConnell EE, Haseman JK., et al Carcinogenesis stud-ies: results of 398 experiments on 104 chemicals from the U.S. National Toxicology Program. Ann NYAcad Sci. 1988; 534: 1–30.
  • Rall DP. Laboratory animal toxicity and carcinogenesis testing. Underlying concepts, advantages and constraints. Ann NY Acad Sci. 1988; 534: 78–83.
  • Rall DP. Carcinogens in our environment. IARC Sci Publ. 1990; 104: 233–9.
  • Huff J, Haseman J, Rall D. Scientific concepts, value, and sig-nificance of chemical carcinogenesis studies. Annu Rev Phar-macol Toxicol. 1991; 31: 621–52.
  • Huff J, Hoel D. Perspective and overview of the concepts and value of hazard identification as the initial phase of risk assess-ment for cancer and human health. Scand J Work Environ Health. 1992;18 suppl 1: 83-9.
  • Huff J, Rall DP. Relevance to humans of carcinogenesis results from laboratory animal toxicology studies, 433-440 8c 453-457. In: Last JM, Wallace RB (eds). Maxcy-Rosenau-Last's Public Health & Preventive Medicine. 13th ed. Norwalk, CT: Appleton & Lange, 1992; 1257 pp.
  • Fung VA, Huff J, Weisburger EK, Hoel DG. Predictive strategies for selecting 379 NCl/NTP chemicals evaluated for carcino-genic potential: scientific and public health impact. Fundam Appl Toxicol. 1993; 20: 413–36. Erratum in: Fundam Appl Toxi-col 1993; 21: 402.
  • Huff J. Issues and controversies surrounding qualitative strate-gies for identifying and forecasting cancer causing agents in the human environment. Pharmacol Toxicol. 1993;72 suppl 1: 12-27.
  • Rail DP. Shoe-leather epidemiology-the footpads of mice and rats: animal tests in assessment of occupational risks. Mt Sinai J Med. 1994; 61: 504–8.
  • Fung VA, Barrett JC, HuffJ. The carcinogenesis bioassay in per-spective: application in identifying human cancer hazards. Env-iron Health Perspect. 1995; 103: 680–3.
  • Rail DP. Can laboratory animal carcinogenicity studies predict cancer in exposed children? Environ Health Perspect. 1995; 103 suppl 6: 173-5.
  • Huff J, Weisburger E, Fung VA. Multicomponent criteria for predicting carcinogenicity: dataset of 30 NTP chemicals. Envi-ron Health Perspect. 1996;104 suppl 5: 1105-12.
  • Huff J. Carcinogenesis results in animals predict cancer risks to humans. Chapter 23: 543-550; 567-569. In: Wallace RB (ed) Maxcy-Rosenau-Last's Public Health & Preventive Medicine. 14th ed. Norwalk, CT: Appleton & Lange, 1998.
  • Huff J. Long-term chemical carcinogenesis bioassays predict human cancer hazards. Issues, controversies, and uncertain-ties. Ann NY Acad Sci. 1999; 895: 56–79.
  • Rall DP. Laboratory animal tests and human cancer. Drug Metab Rev. 2000; 32: 119–28.
  • Tomatis L. Etiologic evidence and primary prevention of cancer. Drug Metab Rev. 2000; 32: 129–37.
  • Tomatis L, Huff J. Evolution of cancer etiology and primary prevention. Environ Health Perspect. 2001; 109: A458–60.
  • Huff J. LkILC monographs, industry influence, and upgrading, downgrading, and under-grading chemicals: a personal point of view. International Agency for Research on Cancer. Int J Occup Environ Health. 2002; 8: 249–70. Erratum in: Int J Occup Environ Health. 2003; 9: 84.
  • Tomatis L, Huff J. Evolution of research on cancer etiology. Chapter 9: 189-201. In: Coleman WB, Tsongalis GJ (eds). The Molecular Basis of Human Cancer: Genomic Instability and Molecular Mutation in Neoplastic Transformation. Totowa, NJ: Humana Press Inc., 2002.
  • Johnson FM, Huff J. Bioassay bashing is bad science. Environ Health Perspect. 2002; 110: A736–7.
  • Melnick RL. Carcinogenicity and mechanistic insights on the behavior of epoxides and epoxide-forming chemicals. Ann NY Acad Sci. 2002; 982: 177–89.
  • Tomatis L. Primary prevention protects public health. Ann NY Acad Sci. 2002; 982: 190–7.
  • Maronpot RR, Flake G, Huff J. Relevance of animal carcino-genesis findings to human cancer predictions and prevention. Toxicol Pathol. 2004;32 suppl 1: 40-8.
  • Huff J, Melnick R, Tomatis L, LaDou J, Teitelbaum D. Trichloroethylene and cancers in humans. Toxicology. 2004; 197: 185–7.
  • Melnick RL, Huff J. Testing toxic pesticides in humans: health risks with no health benefits. Environ Health Perspect. 2004; 112: A459–61.
  • Tomatis L. Primary prevention of cancer in relation to science, sociocultural trends and economic pressures. Scand J Work Environ Health. 2005; 31: 227–32
  • Melnick RL. A Daubert motion: a legal strategy to exclude essential scientific evidence in toxic tort litigation. Am J Public Health. 2005;95 suppl 1: S30-4.
  • Tomatis L. Experimental chemical carcinogenesis: fundamen-tal and predictive role in protecting human health in the 1930s-1970s. Eur J Oncol. 2006; 11: 5–13.
  • Tomatis L. Role of experimental and epidemiological evidence of carcinogenicity in the primary prevention of cancer. Ann 1st Super Sanita. 2006; 42: 113–7.
  • Huff J, Melnick RM. What are the real causes of cancer? An opinionated book review of “Misconceptions about the Causes of Cancer” (Gold LS, Slone TH, Manley NB, Ames BN). Int J Occup Environ Health. 2006; 12: 81–6.
  • Tomatis L. Identification of carcinogenic agents and primary prevention of cancer. Ann NY Acad Sci. 2006; 1076: 1–14.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.